Купирование гипертонического криза

[FRSM]

US recommendations for the use of intravenous
nicardipine and labetolol for treating acute
hypertension in the emergency department
were tested in a multicentre randomised
clinical trial. Of the 226 randomised patients,
110 received nicardipine and 116 labetolol.
Within 30 minutes, the nicardipine group more
often reached the target range of systolic blood
pressure than the labetolol group (92% versus
83%, P=0.039). The need for rescue medication
did not differ between groups, while labetolol
patients had slower heart rates at all times
(Critical Care 2011;15).